| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.66B | $1.73B | $1.73B |
| YoY Revenue Growth % | -3.6% | -0.1% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $365.4M | $463.3M | $459.8M |
| Operating Margin % | 22.0% | 26.9% | 26.6% |
| Net Income (GAAP) | $168.4M | $227.5M | $234.2M |
| EBITDA (Normalized) | $539.4M | $662.0M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $380.1M | $480.1M | $504.9M |
| Capital Expenditures (CapEx) | $217.5M | $248.4M | — |
| Free Cash Flow (FCF) | $162.6M | $231.7M | $504.9M |
| FCF Margin % | 9.8% | 13.4% | 29.2% |
| Return on Invested Capital (ROIC %) | 17.2% | 22.2% | — |
| Cash & Short-Term Equivalents | $99.8M | $115.9M | — |
| Total Debt (Short + Long Term) | $2.22B | $2.23B | — |
| Total Stockholders' Equity | -$435.8M | -$461.5M | — |